Drug
Ionis Agt Lrx
Ionis Agt Lrx: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| IONIS-AGT-LRx NCT04836182 | Phase 2 | Chronic Heart Failure With Reduced Ejection Fraction |
| Ionis AGT-LRx NCT03101878 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Ionis Agt Lrx on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.